Innovus Pharmaceuticals Inc Aktie OTC Bulletin Board
Aktien
US45778V1061
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
|
Manager | Titel | Alter | Seit |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01.06.18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
% 1. Jan. | Kap. | |
---|---|---|
+55,07 % | 815 Mrd. | |
+44,25 % | 654 Mrd. | |
-6,36 % | 354 Mrd. | |
+21,95 % | 337 Mrd. | |
+10,83 % | 302 Mrd. | |
+18,45 % | 247 Mrd. | |
+2,09 % | 229 Mrd. | |
+13,03 % | 219 Mrd. | |
+8,88 % | 171 Mrd. |